Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Research Asia Pacific 2018

About Conference


Oncology Conferences 2018 invites Speakers, Researchers, Exhibitors and Sponsors from everywhere throughout the world to join the Cancer Research Asia Pacific 2018 which will be held amid November 12-13, 2018 in Osaka, Japan.

Cancer Research Asia Pacific 2018 is an International Conference which unites researchers, youthful analysts, students and making the congress an ideal stage to share encounters, pick up and assess rising advancements in Cancer Research and Therapy over the globe.

Cancer Research widely goes from malignancy the study of disease transmission, sub-atomic level research to the execution of clinical preliminaries to assess and analyse uses of the different tumour medications. Numerous treatment choices for malignancy exist. The essential ones incorporate medical procedure, chemotherapy, radiation treatment, hormonal treatment, directed treatment, palliative care and immunotherapy and consolidated treatment modalities, for example, chemo-radiotherapy.

Conference Series LLC Ltd organizes 3000+ Global Events inclusive of 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe and Asia.

Target Audience:

Cancer Researchers, Oncology Professors, Scientists, Radiology and Oncology Researchers, Medical Oncology Faculty, Medical College students, Doctors, Radiology and Oncology Students, Pharmaceutical Industries, Healthcare Industries, Directors of Cancer Research Associations and Societies, Cancer and Radiology Training Institutes.

 

Sessions and Tracks

Track 1: Cancer:

Malignancy is a get-together of contaminations joining unusual cell change with the probability to attack or spread to different parts of the body. These rise up out of liberal tumours, which don't spread to different parts of the body. Possible signs and indications unite a thump, intriguing kicking the pail, conceded hack, unexplained weight diminish, and an adjustment in gut advancements. Tobacco use is the purpose behind around 22% of harm passing. Another 10% are a result of heftiness, awful eating schedule, nonappearance of physical activity, and irrational drinking of alcohol. Diverse factors join certain pollutions, introduction to ionizing radiation and natural toxic substances. In the making scene, 15% of developments are a direct result of maladies, for instance, Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus sullying, Epstein–Barr disease and human immunodeficiency contamination.

  • Prostate cancer
  • Colorectal cancer
  • Oesophageal cancer
  • Breast & ovarian cancer
  • Head and neck cancer
  • Cervical cancer
  • Liver Cancer
  • Pancreatic cancer
  • Brain cancer
  • Gastrointestinal cancer
  • Bile Duct cancer
  • Bladder cancer
  • Bronchial cancer

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

World Cancer Summit 2018 July 02-03, 2018 Bangkok, Thailand; 4th Annual Conference on Gynaecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics July 18-19, 2018 Atlanta, Georgia, USA; 4thAnnual Conference on Preventive Oncology July 18-19, 2018 Atlanta, Georgia, USA; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; International Conference on Cancer Research and Diagnostics August 15-16, 2018 Singapore

Track 2: Cancer Research:

Cancer research is an examine into malignancy to recognize causes and create systems for counteractive action, analysis, treatment, and fix. Tumor explores ranges from the study of disease transmission, sub-atomic bioscience to the execution of clinical preliminaries to assess and think about utilizations of the different growth medications. These applications incorporate medical procedure, radiation treatment, chemotherapy, hormone treatment and immunotherapy and consolidated treatment modalities, for example, chemo-radiotherapy. Beginning in the mid-1990s, the accentuation in clinical malignancy inquire about moved towards treatments got from biotechnology look into, for example, tumor immunotherapy and quality treatment.

Types of Research:       

  • Causes and development of cancer
  • Genes involved in cancer
  • Diagnostics
  • Treatment
  • Clinical Trails
  • epidemiology

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

World Cancer Summit 2018 July 02-03, 2018 Bangkok, Thailand; 4th Annual Conference on Gynaecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics July 18-19, 2018 Atlanta, Georgia, USA; 4thAnnual Conference on Preventive Oncology July 18-19, 2018 Atlanta, Georgia, USA; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; International Conference on Cancer Research and Diagnostics August 15-16, 2018 Singapore

Track 3: Cancer Immunotherapy:

Cancer immunotherapy (in some cases called immuno-oncology, shortened IO) is the utilization of the safe framework to treat tumor. Immune therapies can be sorted as dynamic, latent or cross breed (dynamic and detached). These methodologies abuse the way that disease cells regularly have atoms on their surface that can be identified by the safe framework, known as tumor-related antigens (TAAs); they are frequently proteins or different macromolecules (e.g. starches). Dynamic immunotherapy guides the invulnerable framework to assault tumor cells by focusing on TAAs. Inactive immunotherapies improve existing against tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes and cytokines.

Types of Therapies:

·         Cellular immunotherapy

·         Dendritic Cell therapy

·         CAR-T cell therapy

·         Antibody therapy

·         Cytokine therapy

·         Combination immunotherapy

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

World Cancer Summit 2018 July 02-03, 2018 Bangkok, Thailand; 4th Annual Conference on Gynaecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics July 18-19, 2018 Atlanta, Georgia, USA; 4thAnnual Conference on Preventive Oncology July 18-19, 2018 Atlanta, Georgia, USA; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; International Conference on Cancer Research and Diagnostics August 15-16, 2018 Singapore

Track4: Chemotherapy:

Chemotherapy (Chemo) is a kind of treatment that consolidates a pharmaceutical or mix of medications to treat tumor. The target of chemo is to stop or direct the advancement of development cells. Chemo is seen as a foundational treatment. This suggests it may impact your entire body. Chemo meds strike rapidly creating threat cells, yet they can in like manner impact strong cells that grow rapidly. Chemotherapy is the utilization of any pharmaceutical to treat any ailment. In any case, to a vast number people, the word chemotherapy proposes drugs utilized for affliction treatment. It's from time to time consolidated to "chemo." Surgery and radiation treatment remove, murder, or harm disease cells in a specific region, yet chemo can work all through the entire body. This construes chemo can pound hurt cells that have spread (metastasized) to parts of the body far from the vital (crucial) tumor.

  • Chemotherapy Types
  • Dosage
  • Mechanism of Action
  • Resistance
  • Chemotherapy Side effects

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

4th International Congress on Epigenetics & Chromatin September 03-05, 2018 London, UK; 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2018 Tokyo, Japan; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, California, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2018 Dublin, Ireland

Track 5: Breast cancer:

Breast cancer begins in the cells of the chest. A destructive tumor is a social affair of improvement cells that can frame into and destroy close to tissue. It can in like way metastasize to different parts of the body. Cells in the chest at some part of the time change and never again make or act regularly. These developments may incite non-perilous chest conditions, for example, atypical hyperplasia and wounds. They can in like way actuate non-growth causing tumours, for example, intraductal papilloma’s.

  • Breast cancer screening
  • Reconstruction
  • Lobular carcinoma
  • Abortion–breast cancer hypothesis

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

3rd World Conference on Breast and Cervical Cancer September 24-25, 2018 Abu Dhabi, UAE; 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics October 03-04, 2018 Los Angeles, California, USA; 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery October 03-04, 2018 Los Angeles, California, USA; International Conference on Cancer Diagnosis & Treatment August 2-3 2018 Oslo, Norway; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2018 Dubai, UAE

Track 6: Gynaecologic Cancer Prevention and Control:

A move from treatment to adjusting action of the three noteworthy gynaecologic infirmities: Cervical tumor remains the fourth most standard infection, affecting ladies worldwide with enormous geographic varieties in cervical risk repeat and passing rates.. Basically similarly as with other such pollutions, impediment and spermicidal contraceptives chop down the danger of cervical tumor; the risks reduce evaluated half. Combinational contraceptives help expect both endometrial and epithelial ovarian tumours. The hazard of endometrial tumor among past oral insurance clients is lessened by around half and that of ovarian mischief by around 30% to 80%. Weight control presents solid confirmation against endometrial advancement. Chest empowering and tubal purification seems to ensure against ovarian improvement. Despite the way that ladies have an augmentation, of rational, feasible measures open to decrease their danger of these malignancies, and few consider them. A few attestation based mediations are available to reduce the occasion, distressingness, and mortality from these advancements. The National Comprehensive Cancer Control Program (NCCCP) is astoundingly masterminded to understand these intercessions in the US people.

  • Prevention of cervical cancer
  • Prevention of vulvar cancer
  • Prevention and early detection of vaginal cancer
  • Prevention of epithelial ovarian cancer

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2018 Dubai, UAE; Annual Congress on Cancer and Stem Cell Research October 17-18, 2018 New York, USA; 9th Euro Breast Cancer Summit October 18-19, 2018 Amsterdam, Netherlands; Euro Oncology Summit October 18-19, 2018 Amsterdam, Netherlands; 14th Global Biomarkers Summit October 18-19, 2018 Amsterdam, Netherlands

Track 7:Clinical Oncology:

Clinical Oncology incorporates Medical Oncology (MO), Surgical Oncology (SO), Gynaecologic Oncology, Hematologic Malignancies .Medical oncology conveys the consequences of clinical and test explore in oncology and haematology, especially with exploratory therapeutics with the field of immunotherapy and chemotherapy. A careful and non-careful oncologist has practical experience in the evacuation of the tumours and encompassing tissue amid a task. A careful likewise performs biopsies (the expulsion of a little measure of tissue for examination under a magnifying lens). Hematologic malignancies are types of disease that start in the cells of blood-framing tissue, for example, the bone marrow, or in the cells of the insusceptible framework. Werner disorder (WS), otherwise called "grown-up progeria is an uncommon, autosomal latent progeria disorder (PS), which is portrayed by the presence of untimely maturing. Gynaecologic oncology is a specific field of prescription that spotlights on malignancies of the female conceptive framework, including ovarian disease, uterine growth, vaginal tumor, cervical disease, and vulvar malignancy.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

36th World Cancer Conference October 11-13, 2018 Zurich, Switzerland; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; International Conference on Gastrointestinal Cancer and Therapeutics October 29-30, 2018 San Francisco, California, USA; 26th Annual Congress on Cancer Science and Targeted Therapies October 29-30, 2018 San Francisco, California, USA; 2nd International Conference on Cancer Genetics and Epigenetics November 12-13, 2018 Tokyo, Japan

Track 8:Pediatric Oncology:

Pediatric oncologists are the doctors who have spent significant time in paediatrics and after that got further preparing in medicinal oncology and haematology. This implies as opposed to utilizing medical procedure or radiation treatment to treat disease, Pediatric oncologists normally utilize prescriptions and chemotherapy. Myeloid Leukemia is a sort of Leukemia influencing myeloid tissue. In solution, histiocytosis alludes to an over the top number of histiocytic, (tissue macrophages), and is regularly used to allude to a gathering of uncommon ailments which share this as a trademark. Incidentally and confusingly, the expression "histiocytosis" is now and then used to allude to singular maladies. Intense lymphoblastic leukaemia, otherwise called intense lymphocytic leukaemia or intense lymphoid leukaemia (ALL) is an intense type of Leukemia, or malignancy of the white platelets, portrayed by the overproduction and aggregation of carcinogenic, juvenile white platelets, known as lymphoblast. A mind tumor or intracranial neoplasm happens when strange cells shape inside the cerebrum. There are two fundamental sorts of tumours: threatening tumours and considerate tumours.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

Experts Meet On Cancer Therapy 2018 November 14-15, 2018 Melbourne, Australia; International Conference on Cancer Science & Robotics November 14-15, 2018 Melbourne, Australia; 27th World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology December 07-08, 2018 Chicago, Illinois, USA

Track 9Radiation oncology:

Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. A Radiation Oncologist is a specialist physician who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. Brachytherapy is an advanced cancer treatment. Radioactive seeds or sources are placed in or near the tumour itself, giving a high radiation dose to the tumour while reducing the radiation exposure in the surrounding healthy tissues. External beam therapy (EBT), also called external radiation therapy, is a method for delivering a beam or several beams of high-energy x-rays to a patient's tumour. Intraoperative radiation therapy or IORT is the application of therapeutic levels of radiation to the tumour bed while the area is exposed during surgery. Systemic radiation therapy is a type of radiation therapy in which radioactive material travels through the bloodstream to reach cells all over the body. Systemic radiation is used to treat certain types of cancer, such as thyroid cancer, or to relieve pain when cancer has spread (metastasized) to the bone. Radio immunotherapy (RIT) uses an antibody labelled with a radionuclide to deliver cytotoxic radiation to a target cell. In cancer therapy, an antibody with specificity for a tumour-associated antigen is used to deliver a lethal dose of radiation to the tumour cells.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

World Cancer Summit 2018 July 02-03, 2018 Bangkok, Thailand; 4th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics July 18-19, 2018 Atlanta, Georgia, USA; 4thAnnual Conference on Preventive Oncology July 18-19, 2018 Atlanta, Georgia, USA; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; International Conference on Cancer Research and Diagnostics August 15-16, 2018 Singapore

Track 10: Organ Specific Cancer:

Mind and spinal string tumours might be either amiable (not growth) or threatening (cancer).Both kind and harmful tumours cause signs and side effects and need treatment. Generous cerebrum and spinal rope tumours develop and push on close-by zones of the mind however once in a while spread into different parts of the cerebrum. Dangerous mind and spinal line tumours are probably going to develop rapidly and spread into different parts of the cerebrum. The bones around the nasal pit have little empty spaces in them called paranasal sinuses. These sinuses influence the sound and manner of speaking. The correct reasons for nasal and sinus tumours are not known. Malignancies that are referred to aggregately as head and neck diseases as a rule start in the squamous cells that line the clammy, mucosal surfaces inside the head and neck (for instance, inside the mouth, the nose, and the throat). The most risky type of skin disease is these destructive developments grow once unrepaired DNA harm to skin cells most every now and again caused by bright radiation from daylight or tanning beds triggers transformations hereditary deformities that lead the skin cells to duplicate quickly and frame dangerous tumours. Bosom malignancy is tumor that creates from bosom tissue. Indications of bosom disease may incorporate a knot in the bosom, an adjustment fit as a fiddle, dimpling of the skin, liquid originating from the areola, or a red layered fix of skin. Cervical tumor is a malignancy emerging from the cervix. It is because of the irregular development of cells that can attack or spread to different parts of the body. Pneumonic metastases of renal cell carcinoma (RCC) are related with poor forecast. Inward breath treatment with interleukin-2 (IL-2) is therefore an engaging technique for concealment. Carcinoma of the thyroid organ is an unprecedented growth yet is the most widely recognized harm of the endocrine framework. Separated tumours (papillary or follicular) are very treatable and generally reparable. Hepatocellular carcinoma (HCC, likewise called dangerous hepatoma) is the most well-known sort of liver malignancy. Most instances of HCC are auxiliary to either a viral hepatitis disease (hepatitis B or C) or cirrhosis (liquor abuse being the most widely recognized reason for liver cirrhosis). Conceptive diseases begin in the organs identified with multiplication. These organs are situated in the pelvis. The pelvis is the region in the lower stomach between the hip bones.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

4th International Congress on Epigenetics & Chromatin September 03-05, 2018 London, UK; 15th Asia Pacific Oncologists Annual Meeting September 5-6, 2018 Tokyo, Japan; 28th International Conference on Cancer Research and Anticancer Therapies September 17-18, 2018 San Diego, California, USA; International Conference on Oncogenesis and Oncologic Emergency Medicine September 17-18, 2018 San Diego, California, USA; 3rd Cancer Diagnostics & Treatment Conference November 29-December 01, 2018 Dublin, Ireland

Track 11Cancer: Diagnostics and Staging:

X-radiation (made out of X-beams) is a type of electromagnetic radiation Magnetic reverberation imaging (MRI) is a sort of output that utilizations solid attractive fields and radio waves to create itemized pictures of within the body. A ultrasound filter, in some cases called a sonogram, is a methodology that utilizations high-recurrence sound waves to make a picture of part of within the body. A biopsy is a medicinal test regularly performed by a specialist, interventional radiologist, or an interventional cardiologist including inspecting of cells or tissues for examination. An entire blood check (CBC) gives critical data about the sorts and quantities of cells in the blood, particularly red platelets camera.gif, white platelets camera.gif, and platelets. Malignancy arranging is the way toward deciding the degree to which a growth has created by spreading. The TNM Classification of Malignant Tumours (TNM) is a growth organizing documentation framework that offers codes to depict the phase of a man's disease, when this starts with a strong tumor. Pathologic arranging, where a pathologist looks at segments of tissue, can be especially hazardous for two particular reasons: visual caution and arbitrary inspecting of tissue.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

3rd World Conference on Breast and Cervical Cancer September 24-25, 2018 Abu Dhabi, UAE; 10th Annual Congress on Biomarkers, Clinical Research & Therapeutics October 03-04, 2018 Los Angeles, California, USA; 2nd International Conference on Cancer Biology, Therapeutics and Drug Discovery & Delivery October 03-04, 2018 Los Angeles, California, USA; International Conference on Cancer Diagnosis & Treatment August 2-3 2018 Oslo, Norway; Cancer Genomics Conference: New Era for Cancer Prevention October 08-09, 2018 Dubai, UAE

Track 12:Cancer: Treatment and Therapy:

Different therapeutics are currently accessible to treat disease. Foundational microorganism treatment is the utilization of undeveloped cells to treat or keep a sickness or condition. Quality treatment is the restorative conveyance of nucleic corrosive polymers into a patient's cells as a medication to treat ailment. Quality treatment could be an approach to settle a hereditary issue at its source. A bone marrow transplant is a methodology to supplant harmed or devastated bone marrow with sound bone marrow undifferentiated cells. Immunotherapy is another class of disease treatment that attempts to saddle the inborn forces of the insusceptible framework to battle tumor. Angiogenesis is the arrangement of fresh recruits’ vessels. This procedure includes the relocation, development, and separation of endothelial cells, which line within mass of veins. Hyperthermia is raised body temperature due to fizzled thermoregulation that happens when a body delivers or retains more warmth than it scatters.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2018 Dubai, UAE; Annual Congress on Cancer and Stem Cell Research October 17-18, 2018 New York, USA; 9th Euro Breast Cancer Summit October 18-19, 2018 Amsterdam, Netherlands; Euro Oncology Summit October 18-19, 2018 Amsterdam, Netherlands; 14th Global Biomarkers Summit October 18-19, 2018 Amsterdam, Netherlands

Track 13: Cancer Biomarkers:

Protein Biomarkers can be utilized as biomarkers for early location of malignancies particularly utilized for the distinguishing proof of bosom growth. Symptomatic Patients with suspected pancreatic malignancy will experience an underlying CT sweep to decide whether a presume mass is limited and expelled by medical procedure 63% of patients will be determined to have non-resettable stage III and IV sickness and a biopsy will be embraced to affirm pancreatic disease by H&E neurotic examination. The nearness of carcinogenic cells by means of pathology is exceptionally testing because of high quantities of non-dangerous stromal penetrating cells and organization of chemotherapy or enrolment into a clinical preliminary will just initiate on complete finding of pancreatic growth. These will see particularly recolours neoplastic pancreatic cells would empower the pathologist to certainly analyze pancreatic tumor and along these lines offer suitable disease treatment to the patients. The Novel Biomarker BI-010 has been recognized as a profoundly delicate (98%) and particular (95%) IHC marker for pancreatic tumor and CRT is looking for an accomplice to build up an IHC based test to identify BI-010 in fine needle suction biopsies from biopsy tests.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

36th World Cancer Conference October 11-13, 2018 Zurich, Switzerland; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; International Conference on Gastrointestinal Cancer and Therapeutics October 29-30, 2018 San Francisco, California, USA; 26th Annual Congress on Cancer Science and Targeted Therapies October 29-30, 2018 San Francisco, California, USA; 2nd International Conference on Cancer Genetics and Epigenetics November 12-13, 2018 Tokyo, Japan

Track 14: Cancer: Lifestyle and Nutrition:

Cancer is, an acquired contamination, as if fate and the family quality pool alone direct your chances of ending up sick. A routine is vital to tumor foreknowledge, particularly a regimen concentrated on settling on nutritious decisions, favouring standard sustenance, eating with some confinement and arranging sustenance's honestly. It's about adjust, control and mix. By eating the correct help, utilizing a broad assortment of supplements and not gobbling up more than your body requires, you can help reduce your risk of mischief and various illnesses.

Related Cancer Conferences | Oncology Conferences | Cancer Research and Therapy Conferences

Experts Meet On Cancer Therapy 2018 November 14-15, 2018 Melbourne, Australia; International Conference on Cancer Science & Robotics November 14-15, 2018 Melbourne, Australia; 27th World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology December 07-08, 2018 Chicago, Illinois, USA

Market Analysis

Market Analysis for  CANCER RESEARCH ASIA PACIFIC 2019

Cancer is the second leading cause of death worldwide and in all regions of the world. It has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.

The incidence of all cancers is projected to 20% increase by 2010-2030, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among UAE females (and the most prevalent cancer in both sexes combined), lung cancer, prostate cancer and bowel caners are the most common cancers amongst males but is extremely rare in females, which reflects the prevalence of smoking (23.0% vs. 0.5%, respectively).

Cervical cancer is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females’ worldwide, accounting for 9% (529,800) of the total new cancer cases and 8% (275,100) of the total cancer deaths among females. More than 85% of these cases and deaths occur in developing countries.

Lung cancer is one of the most aggressive tumors and survival after five years is   very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years.

Colorectal cancer (of the colon and rectum), the most common malignant tumors if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer.Prostate cancer, today the most common tumors in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults.

Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

ConferenceSeries LLC Ltd welcomes all the oncologists, radiologists, pathologists, Immunologists research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Oncologists. As this will be the best amalgamation of academia and research involving every aspect and advances in the field of Oncology & cancer. It is open to all types of research methodologies both from academia and industry

The recent advancements in the cancer treatments & cancer care is accelerating. A cluster of innovative treatments, often combined with other new or existing medicines, and frequently associated with biomarkers, are emerging from the research and development pipeline.

Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

  

The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming growth of this market.

Global cancer drugs market accounted for $78,238.9 million in 2015. The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. Global Oncology/Cancer Drugs Market is expected to garner $111.9 billion by 2020, registering a CAGR of 7.1% during the forecast period 2014 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumour cell specific genes.

The global cancer diagnostics market is segmented based on technology, application, and region.

This report studies the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period.

Why Japan?  

Japan is considered as an important centre for higher education and harbours, healthcare, well reputed and prestigious colleges and Universities. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology. Japanese outcomes for high level medical treatment are generally competitive with that of the US. A comparison of two reports in the New England Journal of Medicine  suggest that outcomes for gastro-oesophageal cancer is better in Japan than the US in both patients treated with surgery alone and surgery followed by chemotherapy. Japan excels in the five-year survival rates of colon cancer, lung cancer, pancreatic cancer and liver cancer based on the comparison of a report by the American Association of Oncology and another report by the Japan Foundation for the Promotion of Cancer research. The same comparison shows that the US excels in the five-year survival of rectal cancer, breast cancer, prostate cancer and malignant lymphoma. Surgical outcomes tend to be better in Japan for most cancers while overall survival tend to be longer in the US due to the more aggressive use of chemotherapy in late stage cancers. A comparison of the data from United States Renal Data System (USRDS) 2009 and Japan Reno logy Society 2009 shows that the annual mortality of patients undergoing dialysis in Japan is 13% compared to 22.4% in the US. Five-year survival of patients under dialysis is 59.9% in Japan and 38% in the US.

   Cancer Universities in Japan

  • National Cancer Centre Hospital
  • Aichi Cancer Centre
  • Kyoto Prefectural University of Medicine
  • Tohoku University
  • Kyoto University
  • Chiba University
  • Osaka University

Universities Worldwide

  •  University of Oxford
  • University of Cambridge
  • UCL London's Global University
  • Stanford University
  • Western University
  • University of Nottingham
  • University of Bologna
  • University of Athens
  • University of Chicago
  • University of Washington
  • University of Rochester
  • The University of Melbourne
  • University of Glasgow
  • Fudan University
  • Stanford University
  • University of Minnesota
  • University of Albert
  • University of Nebraska
  • University of Iowa Carver
  • University of Pennsylvania
  • South-western University
  • University of Pittsburgh
  • University of Helsinki
  • University of Penn Medicine

  Universities in Asia

  • Osaka University
  • Tsinghua University
  • Fudan University
  • Taipei Medical University
  • KAIST - Korea Advanced Institute of Science and Technology
  • Yonsei University
  • Shanghai Jiao Tong University
  • Nanyang Technological University (NTU)
  • Chulalongkorn Universit
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan Universit
  •  Indian Institute of Science
  • University Kebangsaan Malaysia (UKM)
  • University Saints Malaysia (USM)
  • Beijing University of Chinese Medicine
  • National Tsing Hua University

Worldwide Societies Associated with Cancer

 

 

Past Conference Report

Oncologists 2017

 

Conferenceseries LLC LTD hosted the “16th Global Annual Oncologists Meeting” during April 24-25, 2017 at JW Marriott Dubai, UAE. Oncologists 2017 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Cancer research and Therapy. The extremely illustrious conference hosted by Conferenceseries LLC LTD was marked with the attendance of young and brilliant researchers, clinicians, business delegates and talented student communities.

The conference was organized around the theme “A step towards Cancer free World. The event implanted a firm relation of upcoming strategies in the field of Oncology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This annual conference brought together eminent scientists, Oncologists, Cancer science researchers, health care professionals, University professors, Oncology professionals in which many issues in Cancer science research were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Cancer science. The eminent personalities at the conference were

  • Dr. Diana Anderson, University of Bradford, UK
  • Dr. Alok De, Kansas City VA Medical Center, USA
  • Dr. Sadir Alrawi, Alzahra Cancer Center, UAE
  • Dr. Ali Aldameh, Al Zahra cancer centre, UAE
  • Dr. Humaid O Al-Shamsi, The University of Texas, USA
  • Dr. Tarek Dufan, American Hospital Dubai, UAE
  • Dr.Jiri Vachtenheim, Charles University, Czech Republic
  • Dr. Mohammed Y Almaghrabi, Prince Faisal Cancer Center, Saudi Arabia 

Conferenceseries LLC LTD offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-Chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Cancer Science & Therapy, Journal of Integrative Oncology and Chemotherapy: Open Access who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Cancer science Research. Conferenceseries LLC LTD therefore, is glad to announce its International Conference on Cancer Research and Therapy during November 12-13, 2018 at Osaka, Japan

Mark your calendars for the upcoming meeting; we are hoping to see you soon!

For More details: https://cancerresearch.cancersummit.org/

Let us meet again @ Cancer Research Asia-Pacific 2018

 

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 12-13, 2018

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Chemotherapy: Open Access Journal of Integrative Oncology Advances in Oncology Research and Treatments

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos